Loxicom 1.5 mg/ml Oral Suspension for Dogs

Oral use.
Initial treatment is a single dose of 0.2 mg meloxicam/kg bodyweight (i.e.
1.33 ml/10 kg bodyweight) on the first day. Treatment is to be continued once daily
by oral administration (at 24 hour intervals) at a maintenance dose of 0.1 mg
meloxicam/kg bodyweight (i.e. 0.667 ml/10 kg bodyweight).
For longer term treatment, once clinical response has been observed (after ≥ 4
days), the dose can be adjusted to the lowest effective individual dose reflecting that
the degree of pain and inflammation associated with chronic musculo-skeletal
disorders may vary over time.
Particular care should be taken with regard to the accuracy of dosing.
The suspension can be given using either of the two measuring syringes provided in
the package (depending on weight of dog). The syringes fit onto the bottle and have
a kg-bodyweight scale which corresponds to the maintenance dose (i.e. 0.1 mg
meloxicam/kg bodyweight). Thus for the first day, twice the maintenance volume will
be required. Alternatively therapy may be initiated with Loxicom 5 mg/ml solution for
injection.
A clinical response is normally seen within 3-4 days. Treatment should be
discontinued after 10 days at the latest if no clinical improvement is apparent.
To be administered with food or directly into the mouth.
Shake well before use.
Avoid introduction of contamination during use.